Glenn Eisenberg compensation by year
LABCORP Summary Compensation Table · all 8 fiscal years held| Component | FY2016 | FY2017 | FY2018 | FY2019 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|
| Salary | $653,438 | $666,474 | $686,662 | $705,500 | $756,287 | $780,500 | $805,462 | $830,462 |
| Bonus | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 |
| Stock awards | $2,799,854 | $1,588,668 | $1,666,134 | $6,966,915 | $3,660,580 | $6,551,496 | $2,473,816 | $2,634,274 |
| Option awards | $0 | $373,349 | $403,747 | $399,081 | $497,470 | $586,988 | $615,878 | $655,645 |
| Non-equity incentive | $679,626 | $746,219 | $621,241 | $715,540 | $1,500,695 | $661,630 | $917,054 | $826,440 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $10,030 | $33,035 | $52,955 | $35,725 | $43,676 | $101,879 | $144,567 | $55,087 |
| Total | $4,142,948 | $3,407,745 | $3,430,739 | $8,822,761 | $6,458,708 | $8,682,493 | $4,956,777 | $5,001,908 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LABCORP HOLDINGS INC. DEF 14A filed April 4, 2025, accession 0001193125-25-072853, and prior-year filings. Open the filing on EDGAR.
How this page was built: the LABCORP HOLDINGS INC. filed document, accession 0001193125-25-072853. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 17,380 | $3,985,582 | — |
| PSU | 15,952 | $3,658,113 | — |
| PSU | 8,305 | $1,904,503 | — |
| RSU | 2,900 | $665,028 | — |
| RSU | 1,770 | $405,896 | — |
| RSU | 807 | $185,061 | — |
| Option | 5,577 | — | $221.67 |
| Option | 2,863 | — | $247.68 |
| Option | 9,000 | — | $222.28 |
Per the Outstanding Equity Awards at Fiscal Year-End table in LABCORP HOLDINGS INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.
LABCORP’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Adam Schechter | President and Chief Executive Officer | $19,327,354 |
| Glenn Eisenberg · this page | Executive Vice President and Former Chief Financial Officer | $5,001,908 |
| Mark Schroeder | Former Executive Vice President and President, Diagnostics and Chief Operations Officer | $3,986,307 |
| Brian Caveney | Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer | $3,567,757 |
| Julia Wang | Executive Vice President and Chief Financial Officer | $3,362,386 |
| Anita Graham | Executive Vice President and Chief Human Resources Officer | $2,685,547 |
The full LABCORP compensation record
free company briefThis page is one person within LABCORP's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the LABCORP proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LABCORP's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.